269 related articles for article (PubMed ID: 10336454)
1. Crystal structure of the Mycobacterium tuberculosis enoyl-ACP reductase, InhA, in complex with NAD+ and a C16 fatty acyl substrate.
Rozwarski DA; Vilchèze C; Sugantino M; Bittman R; Sacchettini JC
J Biol Chem; 1999 May; 274(22):15582-9. PubMed ID: 10336454
[TBL] [Abstract][Full Text] [Related]
2. The X-ray structure of Escherichia coli enoyl reductase with bound NAD+ at 2.1 A resolution.
Baldock C; Rafferty JB; Stuitje AR; Slabas AR; Rice DW
J Mol Biol; 1998 Dec; 284(5):1529-46. PubMed ID: 9878369
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of hexanoyl-CoA bound to β-ketoacyl reductase FabG4 of Mycobacterium tuberculosis.
Dutta D; Bhattacharyya S; Roychowdhury A; Biswas R; Das AK
Biochem J; 2013 Feb; 450(1):127-39. PubMed ID: 23163771
[TBL] [Abstract][Full Text] [Related]
4. Binding of the tautomeric forms of isoniazid-NAD adducts to the active site of the Mycobacterium tuberculosis enoyl-ACP reductase (InhA): a theoretical approach.
Stigliani JL; Arnaud P; Delaine T; Bernardes-Génisson V; Meunier B; Bernadou J
J Mol Graph Model; 2008 Nov; 27(4):536-45. PubMed ID: 18955002
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics simulation studies of the wild-type, I21V, and I16T mutants of isoniazid-resistant Mycobacterium tuberculosis enoyl reductase (InhA) in complex with NADH: toward the understanding of NADH-InhA different affinities.
Schroeder EK; Basso LA; Santos DS; de Souza ON
Biophys J; 2005 Aug; 89(2):876-84. PubMed ID: 15908576
[TBL] [Abstract][Full Text] [Related]
6. Crystallographic and pre-steady-state kinetics studies on binding of NADH to wild-type and isoniazid-resistant enoyl-ACP(CoA) reductase enzymes from Mycobacterium tuberculosis.
Oliveira JS; Pereira JH; Canduri F; Rodrigues NC; de Souza ON; de Azevedo WF; Basso LA; Santos DS
J Mol Biol; 2006 Jun; 359(3):646-66. PubMed ID: 16647717
[TBL] [Abstract][Full Text] [Related]
7. Crystallographic studies on the binding of isonicotinyl-NAD adduct to wild-type and isoniazid resistant 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis.
Dias MV; Vasconcelos IB; Prado AM; Fadel V; Basso LA; de Azevedo WF; Santos DS
J Struct Biol; 2007 Sep; 159(3):369-80. PubMed ID: 17588773
[TBL] [Abstract][Full Text] [Related]
8. A slow, tight binding inhibitor of InhA, the enoyl-acyl carrier protein reductase from Mycobacterium tuberculosis.
Luckner SR; Liu N; am Ende CW; Tonge PJ; Kisker C
J Biol Chem; 2010 May; 285(19):14330-7. PubMed ID: 20200152
[TBL] [Abstract][Full Text] [Related]
9. Roles of tyrosine 158 and lysine 165 in the catalytic mechanism of InhA, the enoyl-ACP reductase from Mycobacterium tuberculosis.
Parikh S; Moynihan DP; Xiao G; Tonge PJ
Biochemistry; 1999 Oct; 38(41):13623-34. PubMed ID: 10521269
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the enoyl-ACP reductase of Mycobacterium tuberculosis (InhA) in the apo-form and in complex with the active metabolite of isoniazid pre-formed by a biomimetic approach.
Chollet A; Mourey L; Lherbet C; Delbot A; Julien S; Baltas M; Bernadou J; Pratviel G; Maveyraud L; Bernardes-Génisson V
J Struct Biol; 2015 Jun; 190(3):328-37. PubMed ID: 25891098
[TBL] [Abstract][Full Text] [Related]
11. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis.
Rozwarski DA; Grant GA; Barton DH; Jacobs WR; Sacchettini JC
Science; 1998 Jan; 279(5347):98-102. PubMed ID: 9417034
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Mycobacterium tuberculosis InhA by 3-nitropropanoic acid.
Songsiriritthigul C; Hanwarinroj C; Pakamwong B; Srimanote P; Suttipanta N; Sureram S; Suttisintong K; Kamsri P; Punkvang A; Spencer J; Kittakoop P; Pungpo P
Proteins; 2022 Mar; 90(3):898-904. PubMed ID: 34677871
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis.
Quémard A; Sacchettini JC; Dessen A; Vilcheze C; Bittman R; Jacobs WR; Blanchard JS
Biochemistry; 1995 Jul; 34(26):8235-41. PubMed ID: 7599116
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
He X; Alian A; Ortiz de Montellano PR
Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
[TBL] [Abstract][Full Text] [Related]
15. Slow-onset inhibition of 2-trans-enoyl-ACP (CoA) reductase from Mycobacterium tuberculosis by an inorganic complex.
Oliveira JS; de Sousa EH; de Souza ON; Moreira IS; Santos DS; Basso LA
Curr Pharm Des; 2006; 12(19):2409-24. PubMed ID: 16842188
[TBL] [Abstract][Full Text] [Related]
16. InhA, the enoyl-thioester reductase from
Vögeli B; Rosenthal RG; Stoffel GMM; Wagner T; Kiefer P; Cortina NS; Shima S; Erb TJ
J Biol Chem; 2018 Nov; 293(44):17200-17207. PubMed ID: 30217823
[TBL] [Abstract][Full Text] [Related]
17. Common themes in redox chemistry emerge from the X-ray structure of oilseed rape (Brassica napus) enoyl acyl carrier protein reductase.
Rafferty JB; Simon JW; Baldock C; Artymiuk PJ; Baker PJ; Stuitje AR; Slabas AR; Rice DW
Structure; 1995 Sep; 3(9):927-38. PubMed ID: 8535786
[TBL] [Abstract][Full Text] [Related]
18. Evidence from Raman spectroscopy that InhA, the mycobacterial enoyl reductase, modulates the conformation of the NADH cofactor to promote catalysis.
Bell AF; Stratton CF; Zhang X; Novichenok P; Jaye AA; Nair PA; Parikh S; Rawat R; Tonge PJ
J Am Chem Soc; 2007 May; 129(20):6425-31. PubMed ID: 17472376
[TBL] [Abstract][Full Text] [Related]
19. Conformational changes in 2-trans-enoyl-ACP (CoA) reductase (InhA) from M. tuberculosis induced by an inorganic complex: a molecular dynamics simulation study.
da Costa AL; Pauli I; Dorn M; Schroeder EK; Zhan CG; de Souza ON
J Mol Model; 2012 May; 18(5):1779-90. PubMed ID: 21833828
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis.
Dessen A; Quémard A; Blanchard JS; Jacobs WR; Sacchettini JC
Science; 1995 Mar; 267(5204):1638-41. PubMed ID: 7886450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
